As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.
Related
Annie Hockey,
Column
Reimagining Fintech [Entire Talk]
The banking industry poses complex regulatory challenges for fintech entrepreneurs — but the space is ripe for innovation.
Annie Hockey,
Column
Reimagining Fintech [Entire Talk]
The banking industry poses complex regulatory challenges for fintech entrepreneurs — but the space is ripe for innovation.
Elise Densborn,
Splendid Spoon
From Customer to Co-CEO [Entire Talk]
Passion for a brand or industry can be an incredible starting point for gaining entrepreneurial experience.
Elise Densborn,
Splendid Spoon
From Customer to Co-CEO [Entire Talk]
Passion for a brand or industry can be an incredible starting point for gaining entrepreneurial experience.
Dante Disparte,
Circle
Ethical Crypto Innovation [Entire Talk]
To build a better crypto industry, start with ethics.
Dante Disparte,
Circle
Ethical Crypto Innovation [Entire Talk]
To build a better crypto industry, start with ethics.
